Zanubrutinib plus R-CHOP for the treatment of newly diagnosed double-expressor lymphoma: A phase 2 clinical study. Yin X, He Q, Liu D, Xie L, et al. Cancer 2025;131:e35697.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yin X, He Q, Liu D, Xie L, et al. Zanubrutinib plus R-CHOP for the treatment of newly diagnosed double-expressor lymphoma: A phase 2 clinical study. Cancer 2025;131:e35697.
PMID: 39748728